A Prospective Study of Sulfonylureas in Patients With Diabetes Due to Kir6.2 Mutations
A Prospective Study of Sulfonylureas in Patients With Diabetes Due to Kir6.2 Mutations
The purpose of this study is to investigate whether patients with diabetes due to Kir6.2 mutations can be treated with sulfonylurea medication rather than insulin, and if this is the case to investigate the mechanism for sulfonylurea response.
Inclusion Criteria:
Exclusion Criteria: